- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02197728
Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy
February 20, 2019 updated by: Unity Health Toronto
We hypothesize, that the use of the Hohl manipulator® at total laparoscopic hysterectomy reduces operative time (from skin incision to detachment of the uterus) and lateral termal damage of the vaginal wall during colpotomy due to the following reasons: (1) Uterine manipulation is better with the Hohl manipulator®, thereby facilitating dissection during all aspects of the surgery, (2) more tension can be applied on the vagina during colpotomy, thereby hastening electrosurgical transection, reducing activation time and reduce lateral thermal damage and (3) tension on the vagina can be applied until the colpotomy is finished, due to the tight connection between the Hohl manipulator® and the cervix of the uterus, which also affects speed of transection, electrosurgical device activation time and lateral thermal damage.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
91
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 1W8
- St. Michael´s Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- All women aged over 18 years, scheduled for a laparoscopic hysterectomy for a benign disorder will be asked to participate and included after written informed consent.
Exclusion Criteria:
- pregnancy
- malignancy
- if uterine size exceeds 20 weeks of gestation
- or if the uterus could be removed by a vaginal approach
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Hohl uterine manipulator ®
Total laparoscopic hysterectomy is performed using the Hohl uterine manipulator ®
|
|
Active Comparator: Colpo-Probe™ Vaginal Fornix Delineator
Total laparoscopic hysterectomy is performed using the Colpo-Probe™ Vaginal Fornix Delineator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Detachment of the uterus
Time Frame: 45 minutes to 3 hours
|
Operative time from skin incision to detachment of uterus.
Times are routinely collected by operating room nursing staff.
|
45 minutes to 3 hours
|
Thermal Damage
Time Frame: 2 weeks post surgery
|
Lateral thermal damage to the vagina will be measured on the specimen (in mm) at the time of pathologic evaluation.
|
2 weeks post surgery
|
Colpotomy
Time Frame: 3 minutes to 20 minutes
|
Time from first monopolar energy activation to completion of colpotomy.
Operative times are routinely collected by operating room nursing staff.
|
3 minutes to 20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Loss
Time Frame: 45 minutes to 3 hours
|
Total amount of blood lost throughout surgery.
Measured in cc.
|
45 minutes to 3 hours
|
Pain
Time Frame: 24h post surgery
|
Amount of post operative pain measured using a pain sensitivity scale.
|
24h post surgery
|
Manipulator Installment
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guylaine Lefebvre, MD, Unity Health Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
May 23, 2014
First Submitted That Met QC Criteria
July 22, 2014
First Posted (Estimate)
July 23, 2014
Study Record Updates
Last Update Posted (Actual)
February 22, 2019
Last Update Submitted That Met QC Criteria
February 20, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 13-326
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Hysterectomy for Benign Conditions
-
University Hospital, Strasbourg, FranceUnknownWomen Who Undergo a Laparoscopic Hysterectomy for Benign Disease.France
-
Istanbul UniversityUniversity of SurreyCompletedTotal Laparoscopic Hysterectomy | Benign ConditionsTurkey
-
Hospices Civils de LyonCompletedBenign Laparoscopic Hysterectomy | Systematic Salpingectomy
-
Memorial Sloan Kettering Cancer CenterCompletedGynecologic Condition | Scheduled for a Total Laparoscopic or Robotic-assisted HysterectomyUnited States
-
Hospital de Concentracion Norte de PetroleosCompletedAbdominal Hysterectomy for Benign DiseaseMexico
-
National Cancer Institute (NCI)CompletedHysterectomy | Oophorectomy for Benign ReasonsUnited States
-
Instituto Nacional de Perinatologia Isidro Espinosa...RecruitingPostoperative Pain | Laparoscopic Hysterectomy for Benign ConditionsMexico
-
ZSX Medical LLCTerminatedLaparoscopic HysterectomyUnited States
-
University of North Carolina, Chapel HillCompletedLaparoscopic HysterectomyUnited States
-
University of North Carolina, Chapel HillCompletedLaparoscopic Hysterectomy and/or Laparoscopic SacrocolpopexyUnited States